Solutions & Services
Therapeutic expertise
Why APICES
We are thrilled to announce that Egle Pavyde has joined APICES CRO as Vice President of Business Development. With over 10 years of experience in the clinical trials field, she brings the expertise needed to help APICES’ clients achieve their research objectives across Europe and global markets.
With a background in pharmacy and a PhD in Life Sciences, Egle combines deep scientific knowledge with strong leadership and strategic insight. Throughout her career, she has successfully driven business growth, cultivated collaborations with pharmaceutical and biotech teams, and helped clients progress and achieve their clinical trial goals.
In her new role at APICES, she will focus on enhancing client engagement, expanding our service offerings, and guiding clients to accelerate their research programs. Her work will empower our clients to progress their studies effectively, ultimately contributing to the development of therapies that improve patient’s health and outcomes.
We are confident that Egle’s arrival will play a key role in strengthening APICES’ client partnerships and driving our growth, while helping clients achieve their research goals. We look forward to collaborating with our clients and partners to deliver high-quality clinical solutions and make a real difference in patients’ lives.
“We are confident that the addition of Egle Pavyde will provide a significant boost in consolidating APICES’ position in the market and strengthening our strategic partnerships. Her experience and leadership will be key to supporting our clients in the development of high-quality clinical research projects,” stated Óscar Salamanca, CEO of APICES.
Interested in achieving your clinical research objectives? Contact APICES and discover how enables progress in clinical studies and improves patient outcomes.
You can find further information in the following link: pmfarma.com/app/noticias/60048-egle-pavyde-se-incorpora-a-apices-como-vicepresidenta-de-business-development
Get the latest clinical insights delivered to your feed or inbox!
On integration, change leadership, and strengthening Apices as one unified organization In a clinical research environment where sponsors value stability, predictability, and quality above all else, organizational change must be approached with care. As APICES...
RWE and HEOR have moved from supporting inputs to decision-critical evidence across development and access. This article summarises what teams are using them for today, how evidence generation is changing, and where AI adds value when paired with the right governance.
Stage III NSCLC care sits at the intersection of multimodal treatment and real-world constraints. The GEOCP-SEOR population-based study describes how patients are managed across Spain, and APICES was acknowledged for supporting the publication through medical editorial assistance.